CD4 and disease arising from reactivation of latent virus: As shown in Fig. 6, we observed that R10015 blocked X4 HIV-1 latent infection of resting CD4 T cells (Fig. 6A); we also observed R10015 dose-dependent inhibition of R5 HIV latent infection of resting memory CD4 T cells (Fig. 6C).